FDA VRBPAC Meeting: Influenza Vaccines for 2026-2027

Agenda (in Eastern Time):

• 9:00 — Opening Remarks: Call to Order and Welcome
• 9:10 — Administrative Announcements, Roll Call, Introduction of Committee, Conflict of Interest Statement
• 9:30 — Open Public Hearing
• 10:30 — Introduction
• 10:45 — U.S. Influenza Surveillance and Preliminary Vaccine Effectiveness Estimates, 2025-26 Season
• 11:10 — Break
• 11:20 — Global Influenza Virus Surveillance and Characterization
• 12:30 — Break
• 1:00 — Department of War Influenza Surveillance and Mid-Season Vaccine Effectiveness
• 1:25 — Candidate Vaccine Strains & Potency Reagents
• 1:45 — Comments from Manufacturer Representative
• 2:10 — Committee Discussion, Recommendations, and Vote
• 3:30 — Closing Remarks and Adjournment